• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

valaydonz@unimelb.edu.au

Credentials


Position
Clinical (Associate Professor)
Department of Medicine

A/Prof Zina Valaydon

Clinical (Associate Professor)
Department of Medicine

12 Scholarly works
1 Projects

HIGHLIGHTS

  • 2024

    Journal article

    Initial Trans-Arterial Chemo-Embolisation (TACE) Is Associated with Similar Survival Outcomes as Compared to Upfront Percutaneous Ablation Allowing for Follow-Up Treatment in Those with Single Hepatocellular Carcinoma (HCC) ≤ 3 cm: Results of a Real-World Propensity-Matched Multi-Centre Australian Cohort Study
    DOI: 10.3390/cancers16173010
  • 2024

    Journal article

    Different Patterns of Care and Survival Outcomes in Transplant-Centre Managed Patients with Early-Stage HCC: Real-World Data from an Australian Multi-Centre Cohort Study
    DOI: 10.3390/cancers16111966
  • 2024

    Journal article

    Surveillance MRI is associated with improved survival in patients with primary sclerosing cholangitis
    DOI: 10.1097/HC9.0000000000000442
  • 2023

    Journal article

    Improved Survival Outcomes with Surgical Resection Compared to Ablative Therapy in Early-Stage HCC: A Large, Real-World, Propensity-Matched, Multi-Centre, Australian Cohort Study
    DOI: 10.3390/cancers15245741
  • 2022

    Journal article

    Epigenetic Silencing of RIPK3 in Hepatocytes Prevents MLKL-mediated Necroptosis From Contributing to Liver Pathologies
    DOI: 10.1053/j.gastro.2022.08.040
  • 2022

    Journal article

    Epidemiology and outcomes of primary sclerosing cholangitis: an Australian multicentre retrospective cohort study
    DOI: 10.1007/s12072-022-10356-1
  • 2021

    Research grants (ARC, NHMRC, MRFF)

    Platform to Enhance Prostate Cancer Shared Care Integration (PEPSI)
Zina Valaydon

RECENT SCHOLARLY WORKS

  • 2022

    Journal article

    Lenvatinib for the treatment of hepatocellular carcinoma—a real-world multicenter Australian cohort study
    DOI: 10.1007/s12072-022-10398-5
  • 2021

    Journal article

    Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients with Difficult to Cure Characteristics
    DOI: 10.1093/cid/ciaa1318
  • 2019

    Conference Proceedings

    Compliance with screening and treatment guidelines is poor for young patients with hepatocellular carcinoma
  • 2019

    Conference Proceedings

    Community Approach Targeting Cirrhosis and Hepatocellular Carcinoma (CATCH) study: Hepatitis B virus infection, screening patterns for hepatocellular carcinoma between general practitioners and non-GP specialists

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224